Menu
Back to Journals » Therapeutics and Clinical Risk Management » Volume 4 » Issue 2
ISSN: 1178-203X
- View all (2487)
- Volume 21, 2025 (93)
- Volume 20, 2024 (86)
- Volume 19, 2023 (91)
- Volume 18, 2022 (104)
- Volume 17, 2021 (134)
- Volume 16, 2020 (134)
- Volume 15, 2019 (154)
- Volume 14, 2018 (271)
- Volume 13, 2017 (188)
- Volume 12, 2016 (217)
- Volume 11, 2015 (210)
- Volume 10, 2014 (113)
- Volume 9, 2013 (57)
- Volume 8, 2012 (47)
- Volume 7, 2011 (59)
- Volume 6, 2010 (66)
- Volume 5, 2009 (102)
- Volume 4, 2008 (148)
- Volume 3, 2007 (126)
- Volume 2, 2006 (47)
- Volume 1, 2005 (40)
Archive: Volume 4, 2008
Towards a new standard of perioperative fluid management
Conor J Shields
Therapeutics and Clinical Risk Management 2008, 4:569-571
Published Date: 11 April 2008
Moderate and severe plaque psoriasis: cost-of-illness study in Italy
GL Colombo, GF Altomare, K Peris, P Martini, G Quarta
Therapeutics and Clinical Risk Management 2008, 4:559-568
Published Date: 11 April 2008
Nonlinear analysis of the heartbeats in public patient ECGs using an automated PD2i algorithm for risk stratification of arrhythmic death
James E Skinner, Jerry M Anchin, Daniel N Weiss
Therapeutics and Clinical Risk Management 2008, 4:549-557
Published Date: 11 April 2008
Cost-effectiveness analysis of electrochemotherapy with the Cliniporator™ vs other methods for the control and treatment of cutaneous and subcutaneous tumors
Giorgio L Colombo, Sergio Di Matteo, Lluis M Mir
Therapeutics and Clinical Risk Management 2008, 4:541-548
Published Date: 11 April 2008
Managing anemia in lymphoma and multiple myeloma
Gunnar Birgegård
Therapeutics and Clinical Risk Management 2008, 4:527-539
Published Date: 11 April 2008
Leuprorelin depot injection: patient considerations in the management of prostatic cancer
Zinelabidine Abouelfadel, E David Crawford
Therapeutics and Clinical Risk Management 2008, 4:513-526
Published Date: 11 April 2008
A review of nasal polyposis
Jonathan Ray Newton, Kim Wong Ah-See
Therapeutics and Clinical Risk Management 2008, 4:507-512
Published Date: 11 April 2008
Prevention of chemotherapy-induced nausea and vomiting: focus on fosaprepitant
Ian N Olver
Therapeutics and Clinical Risk Management 2008, 4:501-506
Published Date: 11 April 2008
Raltegravir: first in class HIV integrase inhibitor
Zelalem Temesgen, Dawd S Siraj
Therapeutics and Clinical Risk Management 2008, 4:493-500
Published Date: 11 April 2008
Use of ethinylestradiol/drospirenone combination in patients with the polycystic ovary syndrome
Ruchi Mathur, Olga Levin, Ricardo Azziz
Therapeutics and Clinical Risk Management 2008, 4:487-492
Published Date: 11 April 2008
New approaches in the treatment of HIV/AIDS – focus on maraviroc and other CCR5 antagonists
Hans P Schlecht, Sarah Schellhorn, Bruce J Dezube, Jeffrey M Jacobson
Therapeutics and Clinical Risk Management 2008, 4:473-485
Published Date: 11 April 2008
Fluticasone furoate nasal spray in the treatment of allergic rhinitis
Pedro Giavina-Bianchi, Rosana Agondi, Rafael Stelmach, Alberto Cukier, Jorge Kalil
Therapeutics and Clinical Risk Management 2008, 4:465-472
Published Date: 11 April 2008
Alemtuzumab in the up-front setting
Matthew Kaufman, Kanti R Rai
Therapeutics and Clinical Risk Management 2008, 4:459-464
Published Date: 11 April 2008
Use of ibandronate in the prevention of skeletal events in metastatic breast cancer
Bianca Devitt, Sue-Anne McLachlan
Therapeutics and Clinical Risk Management 2008, 4:453-458
Published Date: 11 April 2008
Review of the combined contraceptive vaginal ring, NuvaRing®
Frans JME Roumen
Therapeutics and Clinical Risk Management 2008, 4:441-451
Published Date: 11 April 2008
Enfuvirtide antiretroviral therapy in HIV-1 infection
Christina MR Kitchen, Miriam Nuño, Scott G Kitchen, Paul Krogstad
Therapeutics and Clinical Risk Management 2008, 4:433-439
Published Date: 11 April 2008
Review of miglustat for clinical management in Gaucher disease type 1
Can Ficicioglu
Therapeutics and Clinical Risk Management 2008, 4:425-431
Published Date: 11 April 2008
Docetaxel for the post-surgery treatment of patients with node-positive breast cancer
Shubham Pant, Meena P Chilukuri, Bhuvaneswari Ramaswamy
Therapeutics and Clinical Risk Management 2008, 4:419-424
Published Date: 11 April 2008
Single-day treatment for orolabial and genital herpes: a brief review of pathogenesis and pharmacology
Sapna Modi, Livia Van, Aron Gewirtzman, Natalia Mendoza, Brenda Bartlett, et al
Therapeutics and Clinical Risk Management 2008, 4:409-417
Published Date: 11 April 2008
Developments in the management of autosomal dominant polycystic kidney disease
Amirali Masoumi, Berenice Reed-Gitomer, Catherine Kelleher, Mir Reza Bekheirnia, Robert W Schrier
Therapeutics and Clinical Risk Management 2008, 4:393-407
Published Date: 11 April 2008
Update on local anesthetics: focus on levobupivacaine
Crina L Burlacu, Donal J Buggy
Therapeutics and Clinical Risk Management 2008, 4:381-392
Published Date: 11 April 2008
New approaches to managing asthma: a US perspective
William E Berger
Therapeutics and Clinical Risk Management 2008, 4:363-379
Published Date: 11 April 2008
New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide
F Braido, C Lagasio, IMG Piroddi, I Baiardini, GW Canonica
Therapeutics and Clinical Risk Management 2008, 4:353-361
Published Date: 11 April 2008
Treating psoriasis with adalimumab
Eihab A Alwawi, Stephanie L Mehlis, Kenneth B Gordon
Therapeutics and Clinical Risk Management 2008, 4:345-351
Published Date: 11 April 2008
Efficacy and tolerability of lumiracoxib, a highly selective cyclo-oxygenase-2 (COX2) inhibitor, in the management of pain and osteoarthritis
Piet Geusens, Willem Lems
Therapeutics and Clinical Risk Management 2008, 4:337-344
Published Date: 11 April 2008
Treating refractory leukemias in childhood, role of clofarabine
Theresa M Harned, Paul S Gaynon
Therapeutics and Clinical Risk Management 2008, 4:327-336
Published Date: 11 April 2008
Conivaptan: a step forward in the treatment of hyponatremia?
Su Su Hline, Phuong-Truc T Pham, Phuong-Thu T Pham, May H Aung, Phuong-Mai T Pham, Phuong-Chi T Pham
Therapeutics and Clinical Risk Management 2008, 4:315-326
Published Date: 11 April 2008
Zosyn® (piperacillin/tazobactam) reformulation: Expanded compatibility and coadministration with lactated Ringer’s solutions and selected aminoglycosides
Narendra R Desai, Syed M Shah, Jonathan Cohen, Matthew McLaughlin, Hema R Dalal
Therapeutics and Clinical Risk Management 2008, 4:303-314
Published Date: 11 April 2008
“One pill, once daily”: what clinicians need to know about Atripla™
Patrick G Clay, Tracey AH Taylor, Alan G Glaros, MaryPeace McRae, Charlott Williams, et al
Therapeutics and Clinical Risk Management 2008, 4:291-302
Published Date: 11 April 2008